Posters

• P22-01 • A comparison of loop electrosurgical excision procedure using a ring-shaped loop versus a right-angled triangular loop See abstract > J. Jung Eun KIM • P22-02 • Post-Coital Bleeding (PCB) as a Predictor for Cervical Pathology : A cross Sectional Study See abstract > R. Regina AGIZIM • P22-03 • Progression of cervical intraepithelial neoplasia in pregnancy See abstract > D. Donata GRIMM • P22-04 • Association between vaginal microbiome, high risk HPV profile, HPV E6/E7 RNA expression and severity of cervical precancerous lesions See abstract > I. Irina JERMAKOVA • P22-05 • The discovery of a antitumor activity of the alkaloid Erythralin: induction of apoptosis in SiHa cells by arresting the cell cycle at the G2-M phase See abstract > J. Janaina CRISPIM • P22-06 • Citotoxic and pro apoptotic activities of Croton blanchetianus in human cervical cancer HeLa and SiHa cells See abstract > J. Janaina CRISPIM • P24-01 • Vulvar intraepithelial neoplasia-HPV induced pathology? See abstract > M. Mihai MITRAN • P24-02 • Etiological role of human papillomavirus infection in the development of penile cancer See abstract > J. Jiro SAKAMOTO • P25-01 • Factors associated with abnormal anal cytology or HR-HPV anal infection among HIV positive MSM See abstract > F. Filip ROB • P25-02 • HPV genotyping and E6/E7 HPV mRNA expression analyses in anal cytology samples for prevention of HPV-related anal cancer. See abstract > F. Francesca CAROZZI • P25-03 • Anal intraepithelial neoplasia (AIN) and anal squamous cell carcinoma (SCC) in a large urban cohort of HIV-positive individuals living in the United Kingdom: a retrospective data analysis See abstract > J. Jaime VERA • P25-04 • Human papillomavirus (HPV) and the prognosis of Brazilian patients with anal carcinoma See abstract > V. Vera SADDI • P26-01 • HPV detection in oral cavity of asymptomatic people from North Argentina See abstract > G. Gerardo DELUCA • P26-02 • Prevalence of HPV-16 and 18 in patients with oral leukoplakia: a preliminary molecular and immunohistochemical study from a Brazilian cohort See abstract > G. Glauco Issamu MIYAHARA • P26-03 • DNA damage response as tumor selective radiosensitization strategy for HPV positive and negative head and neck cancers See abstract > R. Rüveyda DOK • P27-01 • DNA damage response as tumor selective radiosensitization strategy for HPV positive and negative head and neck cancers > R. Rüveyda DOK • P27-02 • Prevalence and impact on survival of HPV and P16 in oropharyngeal cancer other than tonsil or base of tongue cancer See abstract > L. Linda MARKLUND • P27-03 • Comparison of Anyplex II HPV 28 and SPF10/DEIA/LiPA25 in FFPE oropharyngeal cancer samples See abstract > M. Miquel Angel PAVÓN • P27-04 • The prevalence of HPV in head and neck squamous cell cancer tissues of patients from South-Central Poland See abstract > A. Anna JANECKA-WIDLA • P27-05 • Histological subtype of squamous cell carcinoma of head and neck and the presence of HPV assessed by th immunoxession of P16 See abstract > L. Luiz Martins COLLACO • P27-06 • TP53 and the association to Afatinib response in HNSCC cell lines See abstract > L. Lidia Maria ARANTES • P27-07 • The role of p16 in the metastasis process of human papillomavirus positive head and neck cancers See abstract > M. Mary GLORIEUX • P27-08 • Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: a prospective study See abstract > L. Lars SIVARS • P27-09 • The couple management of HPV infection See abstract > S. Sorin PUIA • P27-10 • Expressed HPV integration events in head and neck cancer: where they occur and their effects on survival and molecular signatures > M. Maureen SARTOR • P27-11 • The prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal carcinoma. See abstract > S. Selvam THAVARAJ • P27-12 • Frequency and clinical outcome of HPV-driven oropharyngeal carcinoma in North-East Italy See abstract > A. Annarosa DEL MISTRO • P27-13 • Prevalence of HPV in branchial cleft cysts and the use of HPV in diagnosis of cystic lesions of the neck See abstract > D. David LANDIN • P27-14 • Expressed HPV integration events in Head and Neck cancer: where they occur and their effect on survival and molecular signatures See abstract > M. Maureen SARTOR • P28-01 • E6 proteins of alpha and beta cutaneous HPV types differ in their ability to potentiate Wnt signaling See abstract > L. Levana SHERMAN • P29-01 • Low vaccine coverage but near extinction of HPV 6 and genital warts in young women in Wolfsburg, Germany See abstract > A. Alexander LUYTEN • P30-01 • Accurate and specific detection of 13 genotypes associated with sexually transmitted disease by PNA mediated real time PCR See abstract > E. Eunji JEONG • P30-02 • HPV infection among HIV-positive men: A four year revised experience of a diagnosis Laboratory. See abstract > A. Ana ALBUQUERQUE • P32-01 • Estimating the epidemiological impact and cost effectiveness of the new nonavalent HPV vaccine in Spain See abstract > N. Noelia LÓPEZ • P32-02 • Gardasil 9: accelerated reduction in the incidence and costs of HPV-related precancerous lesions and cancers See abstract > J. Jens OLSEN • P32-03 • Cost-effectiveness of cervical cancer screening in Europe- a systematic review with specific interest on risk-adapted strategies See abstract > G. Gaby SROCZYNSKI • P34-01 • A survey of HPV knowledge and attitudes toward HPV vaccination among the middle school students and their parents in China See abstract > X. Xiang Xian FENG • P34-02 • HPV- What do they know: evaluation of medicine students and health professionals- Valença- Rio de Janeiro/ Brazil See abstract > F. Filomena SILVEIRA • P36-01 • Well-Child Visits and HPV Vaccination in Preteenagers Aged 11-12 Years during 2007-2015 in the United States See abstract > S. Smita KOTHARI • P36-02 • Acceptability and short-term effects of an HPV vaccination intervention for young gay and bisexual men in the United States See abstract > P. Paul REITER • P36-03 • Digital Interventions to Improve HPV Vaccine Uptake See abstract > W. William WOODALL • P36-04 • Croatian pathway in implementing HPV vaccination (2007.-2017.) See abstract > N. Neda FERENCIC VRBAN • P36-05 • HPV prevalence and associated risk factors in women with cervical pre-cancer and cancer in Switzerland at the beginning of the cantonal vaccination programmes: The CIN3+plus study See abstract > A. Anne SPAAR • P36-06 • HPV vaccine acceptability for daughters among at-risk women in Brazil See abstract > L. Laura MUSSELWHITE • P36-07 • Stratifying a screening population into risk categories-personalising a cervical cancer screening programme See abstract > N. Nicolas BALTZER